tiprankstipranks
Advertisement
Advertisement
Clearmind reports positive retention results for intranasal formulation of MEAI
PremiumThe FlyClearmind reports positive retention results for intranasal formulation of MEAI
15d ago
FDA announces availability of final guidance for psychedelic drug research
Premium
The Fly
FDA announces availability of final guidance for psychedelic drug research
16d ago
Clearmind Medicine submits response to HHS request for information
Premium
The Fly
Clearmind Medicine submits response to HHS request for information
21d ago
Psychedelic: Clearmind completes Part A dosing for Phase I/II CMND-100 trial
PremiumThe FlyPsychedelic: Clearmind completes Part A dosing for Phase I/II CMND-100 trial
1M ago
Clearmind Medicine granted U.S. patent for Binge Behavior Regulators
Premium
The Fly
Clearmind Medicine granted U.S. patent for Binge Behavior Regulators
1M ago
Clearmind Medicine completes dosing for four cohorts of CMND-100 trial
Premium
The Fly
Clearmind Medicine completes dosing for four cohorts of CMND-100 trial
2M ago
Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings
PremiumThe FlyPsychedelic: Enveric, NRx, Bright Minds report quarterly earnings
2M ago
Clearmind Medicine Inc trading halted, news pending
Premium
The Fly
Clearmind Medicine Inc trading halted, news pending
2M ago
Clearmind Medicine announces 1-for-10 reverse share split
Premium
The Fly
Clearmind Medicine announces 1-for-10 reverse share split
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100